The emerging therapy of this peptide represents a significant breakthrough in the management of type 2 diabetes. Unlike existing medications, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide204831.timeblog.net/78014036/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment